| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ALX Oncology Holdings (NASDAQ:ALXO) is set to give its latest quarterly earnings report on Tuesday, 2025-08-12. Here's what investors need to know before the announcement.
Analysts estimate that ALX Oncology Holdings will report an earnings per share (EPS) of $-0.37.
Anticipation surrounds ALX Oncology Holdings's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
The company's EPS missed by $0.14 in the last quarter, leading to a 8.24% drop in the share price on the following day.
Here's a look at ALX Oncology Holdings's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.340 | -0.39 | -0.78 | -0.77 |
| EPS Actual | -0.477 | -0.44 | -0.45 | -0.62 |
| Price Change % | -8.0% | -19.0% | -4.0% | -1.0% |
Shares of ALX Oncology Holdings were trading at $0.6768 as of August 08. Over the last 52-week period, shares are down 76.14%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for ALX Oncology Holdings visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ALXO
